Sehested, T. S. G., Bjerre, J., Ku, S., Chang, A., Jahansouz, A., Owens, D. K., . . . Goldhaber-Fiebert, J. D. (2019). Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events. JAMA Cardiol.
Chicago ZitierstilSehested, Thomas S. G., Jenny Bjerre, Seul Ku, Andrew Chang, Alison Jahansouz, Douglas K. Owens, Mark A. Hlatky, und Jeremy D. Goldhaber-Fiebert. "Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events." JAMA Cardiol 2019.
MLA ZitierstilSehested, Thomas S. G., et al. "Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events." JAMA Cardiol 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.